Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of TQB3126 in breast cancer
CTR20262662Phase 2Active
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TQB3126 in breast cancer, sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Sep 2026; status: active.
02
Drugs
TQB3126
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20262662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262662.